Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Francesco Sponziello"'
Autor:
Saverio Cinieri, M.C. Chetri, Angelo Nacci, Nicola Calvani, Palma Fedele, E. Mazzoni, Laura Orlando, Chiara Caliolo, A. Marino, Annamaria Quaranta, Pasqualinda Ferrara, Margherita Cinefra, Paola Schiavone, Francesco Sponziello, Stefania Eufemia Lutrino, P. Rizzo, M. D'Amico
Publikováno v:
Tumori Journal. 101:524-528
Aims and background Few data describe the activity of panitumumab after cetuximab-irinotecan-based regimen failure in patients with KRAS wild-type metastatic colorectal cancer (WT MCRC). Methods The aim of this study is to assess if panitumumab has s
Autor:
Andrea Onetti Muda, Guido Giordano, Gianni Simone, Pietro Micheli, C. Barone, Giacomo Cartenì, Fabiana Tatangelo, Laura Longhitano, Vincenzo Rosario Iaffaioli, Alessandra Cassano, M. Biglietto, Anna Nappi, Sabrina Rossi, A.R. Bordonaro, A. Rinaldi, Francesco Sponziello, G. Modoni, GabrieleDi Maggio, Matilde Lambiase, Oscar Nappi, Claudia Cardone, Antonella Marino, Mirko Montrone, Sandro Barni, Michele Orditura, Antonio Febbraro, Paolo Graziano, Saverio Cinieri, Guglielmo Nasti, Fortunato Ciardiello, Evaristo Maiello, D. Rizzi, Vincenzo Sforza, Stefano Cordio, F. De Vita, Erika Martinelli, S. Romito, Vincenzo Montesarchio, Giuseppe Tonini, Annamaria Sebastio, Salvatore Pisconti, Nicola Normanno, Tiziana Guarino, Giuseppe Colucci, Francesco Giuliani, Anna Maria Rachiglio, Gerardo Botti, Nicoletta Chicchinelli, Tiziana Latiano, Teresa Troiani, Vito Lorusso, Michele Aieta, Silvana Leo, Giuseppe Grimaldi, Eugenio Tommaselli, Luigi Leo, Cinzia Chiarazzo, Mario Manusia
Publikováno v:
ESMO Open
In the cetuximab after progression in KRAS wild-type colorectal cancer patients (CAPRI) trial patients with metastatic colorectal cancer (mCRC) received 5-fluorouracil, folinic acid and irinotecan (FOLFIRI) and cetuximab in first line followed by 5-F
Autor:
P. Rizzo, A. Marino, Vito Lorusso, Rosa Chiara Forcignanò, Laura Orlando, Saverio Cinieri, Angelo Nacci, Nicola Calvani, Palma Fedele, E. Mazzoni, Francesco Sponziello, Mariangela Ciccarese, Paola Schiavone
Publikováno v:
Journal of Chemotherapy. 25:369-375
To explore clinical outcomes and cardiac safety of continuous antiHer2 therapy.This retrospective study evaluates overall survival (OS), time to treatment failure (TTF), and cardiac safety of 80 consecutive Her2-positive metastatic breast cancer (MBC
Autor:
Francesco Sponziello, Saverio Cinieri, Giuseppe Grimaldi, Alessandra Cassano, M. Biglietto, Pietro Micheli, Gianni Simone, C. Barone, Fabiana Tatangelo, Antonella Marino, Giacomo Cartenì, Guglielmo Nasti, D. Rizzi, Antonio Febbraro, Cinzia Chiarazzo, Mario Manusia, Vito Lorusso, Fortunato Ciardiello, A.R. Bordonaro, S. Romito, Sabrina Rossi, Teresa Troiani, F. De Vita, Eugenio Tommaselli, Giuseppe Colucci, Andrea Onetti Muda, Guido Giordano, Luigi Leo, G. Modoni, Annamaria Sebastio, Sandro Barni, Francesco Giuliani, Paolo Graziano, M. Rachiglio, Michele Aieta, Evaristo Maiello, Enrica Martinelli, Mirko Montrone, Silvana Leo, Tiziana Latiano, Stefano Cordio, Laura Longhitano, Vincenzo Rosario Iaffaioli, Vincenzo Montesarchio, Nicola Normanno, Anna Nappi, Matilde Lambiase, Gerardo Botti, Gabriele Di Maggio, Giuseppe Tonini, Nicoletta Chicchinelli, Oscar Nappi, Claudia Cardone, Michele Orditura, A. Rinaldi, Salvatore Pisconti, Tiziana Guarino
Background Cetuximab plus chemotherapy is a first-line treatment option in metastatic KRAS and NRAS wild-type colorectal cancer (CRC) patients. No data are currently available on continuing anti-epidermal growth factor receptor (EGFR) therapy beyond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343fea2703fb6409297f48937f6f6bde
http://hdl.handle.net/11591/354385
http://hdl.handle.net/11591/354385
Autor:
Francesco Sponziello, A. Marino, Paola Schiavone, M. D'Amico, E. Mazzoni, Nicola Silvestris, Franco Morelli, Nicola Calvani, Saverio Cinieri, Laura Orlando, Angelo Nacci, Margherita Cinefra, Palma Fedele, Lucia Lombardi
Publikováno v:
Expert Opinion on Therapeutic Targets. 16:S83-S89
The chance to take advantage of genetic defects of cancer cells is a promising clinical tool in breast cancer therapy. Among the genetic aberrations, dysfunctions in DNA repair mechanisms are quite common and suitable for an attractive antitumor effe
Autor:
M. D'Amico, E. Mazzoni, M.C. Chetri, M. Caloro, Chiara Caliolo, L.L. Falcone, P. Rizzo, Paola Schiavone, Saverio Cinieri, Angelo Nacci, D. Loparco, E.S. Lutrino, Annamaria Quaranta, Francesco Sponziello, N. Calvani, Margherita Cinefra, L. Orlando, A. Marino, Palma Fedele, P. Ferrara
Publikováno v:
Annals of Oncology. 28:vi35-vi36
Autor:
P. Rizzo, N. Calvani, Palma Fedele, M. D'Amico, Annamaria Quaranta, Francesco Sponziello, E. Mazzoni, Saverio Cinieri, P. Ferrara, Margherita Cinefra, Angelo Nacci, M.C. Chetri, A. Lanzilotti, M. Caloro, Paola Schiavone, A. Marino, D. Loparco, E.S. Lutrino, Chiara Caliolo, L. Orlando
Publikováno v:
Annals of Oncology. 29:viii637
Autor:
Chiara Caliolo, M. D'Amico, Saverio Cinieri, D. Loparco, Francesco Sponziello, E.S. Lutrino, Angelo Nacci, A. Marino, G. Aprile, M. Caloro, P. Ferrara, N. Calvani, M.C. Chetri, E. Mazzoni, Annamaria Quaranta, Margherita Cinefra, Palma Fedele, Paola Schiavone, L. Orlando, P. Rizzo
Publikováno v:
Annals of Oncology. 28:vi32
Autor:
Dario Loparco, M.C. Chetri, E. Mazzoni, A. Marino, Chiara Caliolo, M. D'Amico, Margherita Cinefra, P. Rizzo, Paola Schiavone, Palma Fedele, Stefania Eufemia Lutrino, Nicola Calvani, Manuela Caloro, Francesco Sponziello, Pasqualinda Ferrara, Annamaria Quaranta, Laura Orlando, Saverio Cinieri, Angelo Nacci
Publikováno v:
Journal of Clinical Oncology. 35:e12016-e12016
e12016 Background: Alopecia (A) is one of the most emotionally distressing side effects of chemotherapy (CT). CT-induced A may lead to a negative body image, contributing to worsen the quality of life (QoL). The cancer treatments, especially in breas
Autor:
Caterina Fontanella, Chiara Caliolo, M. D'Amico, M.C. Chetri, P. Ferrara, E. Mazzoni, Francesco Sponziello, P. Rizzo, Palma Fedele, Annamaria Quaranta, L. Orlando, Saverio Cinieri, Angelo Nacci, A. Marino, N. Calvani, E.S. Lutrino, Margherita Cinefra, Paola Schiavone
Publikováno v:
Annals of Oncology. 26:vi17